ES2123973T3 - Afamina: una proteina similar a la seroalbumina humana. - Google Patents

Afamina: una proteina similar a la seroalbumina humana.

Info

Publication number
ES2123973T3
ES2123973T3 ES95915503T ES95915503T ES2123973T3 ES 2123973 T3 ES2123973 T3 ES 2123973T3 ES 95915503 T ES95915503 T ES 95915503T ES 95915503 T ES95915503 T ES 95915503T ES 2123973 T3 ES2123973 T3 ES 2123973T3
Authority
ES
Spain
Prior art keywords
human
afamina
protein similar
seroalbumine
human seroalbumine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95915503T
Other languages
English (en)
Inventor
Henri Stephen Lichenstein
David Edwin Lyons
Mark Matsuo Wurfel
Samuel Donald Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rockefeller University
Amgen Inc
Original Assignee
Rockefeller University
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rockefeller University, Amgen Inc filed Critical Rockefeller University
Application granted granted Critical
Publication of ES2123973T3 publication Critical patent/ES2123973T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A UNA NUEVA PROTEINA DE SUERO HUMANO DENOTADA COMO AFM, QUE TIENE UNA O MAS ACTIVIDADES EN COMUN CON LA ALBUMINA DE SUERO HUMANO, A-FETOPROTEINA HUMANA, O PROTEINAS DE UNION DE LA VITAMINA D HUMANA Y QUE TIENEN UN PESO MOLECULAR APARENTE POR SDS-PAGE DE 87 KD; VARIANTES DE ESTAS; Y GENES, VECTORES, CELULAS Y METODOS.
ES95915503T 1994-03-31 1995-03-31 Afamina: una proteina similar a la seroalbumina humana. Expired - Lifetime ES2123973T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/222,619 US5652352A (en) 1994-03-31 1994-03-31 Afamin: a human serum albumin-like gene

Publications (1)

Publication Number Publication Date
ES2123973T3 true ES2123973T3 (es) 1999-01-16

Family

ID=22832990

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95915503T Expired - Lifetime ES2123973T3 (es) 1994-03-31 1995-03-31 Afamina: una proteina similar a la seroalbumina humana.

Country Status (11)

Country Link
US (2) US5652352A (es)
EP (1) EP0754229B1 (es)
JP (1) JPH09511399A (es)
AT (1) ATE173014T1 (es)
AU (1) AU691607B2 (es)
CA (1) CA2186516A1 (es)
DE (1) DE69505804T2 (es)
DK (1) DK0754229T3 (es)
ES (1) ES2123973T3 (es)
MX (1) MX9604402A (es)
WO (1) WO1995027059A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060014143A1 (en) * 1995-06-07 2006-01-19 Nobuto Yamamoto Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis
US6410269B1 (en) * 1995-06-07 2002-06-25 Nobuto Yamamoto Preparation of potent macrophage activating factors derived from cloned vitamin D binding protein and its domain and their therapeutic usage for cancer, HIV-infection and osteopetrosis
US7208576B2 (en) * 1999-01-06 2007-04-24 Merrimack Pharmaceuticals, Inc. Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
AT407675B (de) * 1999-06-25 2001-05-25 Vita Tech Illmensee Dieplinger Verfahren zur fertilitätsbestimmung von säugetieren, insbesondere von menschen
JP4336771B2 (ja) * 2001-03-09 2009-09-30 モルフォシス アーゲー 血清アルブミン結合部分
AT411014B (de) * 2001-04-30 2003-09-25 Vitateq Biotechnology Gmbh Präparationen von vitamin e in kombination mit afamin
EP1463751B1 (en) 2001-12-21 2013-05-22 Human Genome Sciences, Inc. Albumin fusion proteins
CA2489596A1 (en) * 2002-06-14 2003-12-24 Dyax Corporation Protein analysis
JP4492156B2 (ja) * 2004-03-03 2010-06-30 ニプロ株式会社 血清アルブミンドメインを含む蛋白質
AT501348B1 (de) * 2005-01-31 2008-10-15 Vitateq Biotechnology Gmbh Verfahren zur tumordiagnose
EP2035830B1 (en) * 2006-06-14 2015-03-25 Johns Hopkins University Albumin-bound protein/peptide complex as a biomarker for disease
AT505727B1 (de) 2007-09-04 2009-06-15 Univ Innsbruck Verfahren zur diagnose des metabolischen syndroms
US20140127703A1 (en) 2011-06-28 2014-05-08 Vitateq Biotechnology Gmbh Method for Diagnosing Preeclampsia
GB2511525A (en) * 2013-03-05 2014-09-10 Randox Teoranta Methods and Compositions for the Diagnosis of Alzheimer's Disease
JP2016188761A (ja) * 2013-08-23 2016-11-04 国立研究開発法人国立国際医療研究センター 糖尿病腎症の発症または発症リスクの検出方法及びキット
EP3037824A1 (en) 2014-12-22 2016-06-29 Vitateq Biotechnology GmbH Method for the detection and/or quantification of afamin
EP3581584B1 (en) 2014-12-24 2022-03-30 Osaka University Method for producing wnt protein and method for storing wnt protein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1226551B (it) * 1988-07-29 1991-01-24 Sclavo Spa Peptide sintetico immunologicamente attivo capace di indurre la produzione di anticorpi con elevata specificita' verso l'alfa- fetoproteina e loro impiego in campo diagnostico
US6268212B1 (en) * 1993-10-18 2001-07-31 Amgen Inc. Tissue specific transgene expression

Also Published As

Publication number Publication date
CA2186516A1 (en) 1995-10-12
JPH09511399A (ja) 1997-11-18
US5767243A (en) 1998-06-16
AU2236795A (en) 1995-10-23
EP0754229B1 (en) 1998-11-04
DE69505804T2 (de) 1999-07-08
US5652352A (en) 1997-07-29
DE69505804D1 (de) 1998-12-10
MX9604402A (es) 1997-07-31
WO1995027059A1 (en) 1995-10-12
ATE173014T1 (de) 1998-11-15
EP0754229A1 (en) 1997-01-22
DK0754229T3 (da) 1999-07-19
AU691607B2 (en) 1998-05-21

Similar Documents

Publication Publication Date Title
ES2123973T3 (es) Afamina: una proteina similar a la seroalbumina humana.
BG104149A (en) Interleukin-18-binding proteins, methods for their preparation and administration
EA199800946A1 (ru) Концентрированный препарат антител
AR001731A1 (es) Nueva celulasa método para producirla composición que la contiene vector que comprende al adn que lacodifica celula huesped método de aplicación
CA2045869A1 (en) Fusion proteins with immunoglobulin portions, the preparation and use thereof
ATE223229T1 (de) Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
DE69434384D1 (de) Metalkomplexbildner
ATE186738T1 (de) Kohlenhydratmodifizierte cytostatika
DE69634489D1 (de) Adenovirus dodekahedrischer proteinkomplex, dieser enthaltende zusammensetzung und verwendungen davon
DE69634077D1 (de) Haemophilus adhäsionsproteinen
MX9602557A (es) Proteinas de higado de mamifero y su uso en oncologia.
IL187595A0 (en) Antitumor antibodies, proteins, and uses thereof
SE9501067D0 (sv) New peptides
ATE139541T1 (de) Kollagen-bindendes protein sowie dessen herstellung
DE69737476D1 (de) Neuer galaninrezeptor
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
WO1996002572A3 (fr) Sequence polypeptidique antigenique du facteur viii, fragments et/ou epitopes de celle-ci
DK1431391T3 (da) RANTES-mutanter og terapeutiske anvendelser heraf
WO1996016170A3 (en) Proteins involved in the regulation of cell-cell adhesion and uses thereof
BR0113623A (pt) Proteìnas sintéticas de estìmulo da eritropoiese
CA2385766A1 (en) Methods for production of proteins in host cells
SE9604439D0 (sv) New receptor
WO2001018194A3 (en) Maize casein kinase 1 orthologue and uses thereof
ITPC930011A0 (it) Composizione cosmetica contenente proteine dello yogurt ed estratto dibetulla, per la reparazione di prootti tricologici.
ITRM920853A0 (it) Innovazioni tecniche nella macchina riproducente la cosiddetta realta'virtuale.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 754229

Country of ref document: ES